Apollomics APLM
NASDAQ APLM
$23.86 -1.02 (-4.04%)
As of: Sep 10, 2026 · 11:04 AM EDT

Apollomics (APLM) Current Assets (2021 - 2025)

Apollomics' (APLM) quarterly Current Assets came in at $6.1 million in Q4 2025, down 41.06% year-over-year from $10.3 million in Q4 2024, and down 40.26% quarter-over-quarter from $10.1 million in Q2 2025.

Analysis

Apollomics (APLM) Current Assets (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Current Assets for 5 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Current Assets fell 41.06% year-over-year to $6.1 million in Q4 2025; TTM through Dec 2025 was $6.1 million, a 41.06% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, down 41.06% from the prior year.
  • Current Assets was $6.1 million for Q4 2025 at Apollomics, down from $10.1 million in the prior quarter.
  • Over five years, Current Assets peaked at $55.4 million in Q2 2023 and troughed at $2.3 million in Q4 2023.
  • A 5-year average of $15.6 million and a median of $8.3 million in 2021 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets soared 340.64% in 2024 and plunged 64.35% in 2025, its largest moves.
  • Over 5 years, Current Assets stood at $6.5 million in 2021, then declined by 7.48% to $6.0 million in 2022, then sank by 61.17% to $2.3 million in 2023, then jumped by 340.64% to $10.3 million in 2024, then sank by 41.06% to $6.1 million in 2025.
  • The last three Current Assets figures came in at $6.1 million (Q4 2025), $10.1 million (Q2 2025), and $10.3 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 8.07 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.62 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 7.31 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 4.74 Bn
10 Apollomics 34.50 Mn 31.23 Mn - 6.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.05 Mn
Jun 30, 2025 10.13 Mn
Dec 31, 2024 10.27 Mn
Jun 30, 2024 28.41 Mn
Dec 31, 2023 2.33 Mn
Jun 30, 2023 55.38 Mn
Dec 31, 2022 6.00 Mn
Dec 31, 2021 6.49 Mn